Cover Image
市場調查報告書

中國的Parecoxib市場分析

Investigation Report on China Parecoxib Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 334086
出版日期 內容資訊 英文 25 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的Parecoxib市場分析 Investigation Report on China Parecoxib Market, 2010-2019
出版日期: 2015年07月02日 內容資訊: 英文 25 Pages
簡介

Parecoxib自從打入中國市場以來便急速成長。年度銷售額從2008年的2,000萬人民幣,2014年達成2億人民幣,達到了年複合成長率54.70%的成長。

本報告提供中國的Parecoxib市場相關調查分析,提供您市場規模,競爭情形,各企業的零售價格,市場預測相關的系統性資訊。

第1章 Parecoxib的相關概念

  • 適應
  • 全球市場銷售情形

第2章 中國的Parecoxib的市場簡介

  • 中國的Parecoxib的專利·核準情況
  • 主要製造商
  • 市場規模

第3章 中國的Parecoxib銷售分析

  • 銷售額
  • 銷售額數量

第4章 中國的Parecoxib主要廠商的市場佔有率分析

  • 市場佔有率:銷售額別
  • 市場佔有率:銷售量別

第5章 中國的Parecoxib的各劑型分析

  • 市場佔有率 (各劑型) :銷售額別
  • 市場佔有率 (各劑型) :銷售量別

第6章 中國的Parecoxib的醫院用標準價格

第7章 中國市場的Parecoxib的主要製造商

第8章 中國的Parecoxib的市場預測

  • 市場規模的預測
  • 競爭情形的預測

圖表

目錄
Product Code: 1507247

For a long time, opioid has been one of the main drugs for the treatment of moderate and severe pain following surgery. However, as people's knowledge deepens, more and more doctors and patients come to realize that opioid is not really safe. Relevant studies show that opioid alone doesn't work effectively on pain resulting from exercises and that is not conducive to postoperative exercise and recovery. Besides, the use of opioid after surgery can cause such side effects as nausea, vomiting, sedation and uroschesis which are dose-dependent.

Parecoxib is a kind of COX-2 inhibitor which compared with opioid, can effectively inhibit COX-2 expression and reduce the synthesis of prostaglandin in the central and peripheral nervous system, inhibit hyperalgesia and increase pain threshold. Parecoxib's analgesia has been confirmed in studies conducted by anesthesia department, department of orthopaedics, gynecology and general surgery department. And its combination of fast lasting pain relief and safety has made it a better choice for postoperational analgesia.

Parecoxib, the first COX-2 inhibitor which can be injected through vein and muscle, was developed by Pharmacia & Upjohn and approved to enter Europe under the trade name of Dynastat in early 2002. Currently, it has been marketed in over 10 countries in the world.

Parecoxib develops fast after entering China in 2008. According to CRI's market survey, its annual sales value rose from less than CNY 20 million in 2008 to over CNY 200 million in 2014 with CAGR during this period reaching 54.70%. Currently, parecoxib in the Chinese market is monopolized by Upjohn that brought in a sales value of CNY 204 million in 2014.

It is possible for local parecoxib to come into the market in the next few years. And the market size of parecoxib in China is expected to keep growing.

Readers can get at least the following information from this report:

  • market size of parecoxib in China
  • competitive landscape of parecoxib in Chinese market
  • price of parecoxib made by different enterprises in China
  • market outlook of parecoxib in China

The author suggests the following groups of people purchase this report:

  • manufacturers of analgesic
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Parecoxib

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Parecoxib in China

  • 2.1. Patent and Approval Status of Parecoxib in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Parecoxib in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Parecoxib in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Parecoxib in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Parecoxib in Chinese Hospitals in 2014

7. Major Manufacturers of Parecoxib in Chinese Market, 2010-2014

8. Market Outlook of Parecoxib in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Patent Status of Parecoxib in China
  • Chart Sales Status of Parecoxib in China
  • Chart Sales Value of Parecoxib in China, 2010-2014
  • Chart Sales Value of Parecoxib in Some Regions in China, 2010-2014
  • Chart Sales Volume of Parecoxib in China, 2010-2014
  • Chart Sales Volume of Parecoxib in Some Regions in China, 2010-2014
  • Chart Sales Value and Market Share of Parecoxib Made by Upjohn (US) in China, 2010-2014
  • Chart Sales Value and Market Share of Parecoxib Injections in China, 2010-2014
  • Chart Sales Volume and Market Share of Parecoxib Injections in China, 2010-2014
  • Chart Price of Parecoxib Made by Upjohn (US) in Some Chinese Cities in 2014
Back to Top